| Name | Title | Contact Details |
|---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Statim is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Trius Therapeutics Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Diego, CA. To find more information about Trius Therapeutics Inc., please visit www.triusrx.com
Blue Cross and Blue Shield of Mississippi (BCBSMS) is a Jackson, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Esoterix Clinical Trial Services is a Cranford, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.